NOVARTIS | SHRENIK | NOVARTIS/ SHRENIK |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.3 | -0.6 | - | View Chart |
P/BV | x | 3.4 | 1.0 | 326.3% | View Chart |
Dividend Yield | % | 4.5 | 0.0 | - |
NOVARTIS SHRENIK |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
SHRENIK Mar-23 |
NOVARTIS/ SHRENIK |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 3 | 22,783.6% | |
Low | Rs | 554 | 2 | 32,588.2% | |
Sales per share (Unadj.) | Rs | 153.4 | 0.8 | 19,334.3% | |
Earnings per share (Unadj.) | Rs | 41.9 | 0 | 1,118,786.8% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 0 | 381,467.4% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | 1.0 | 32,335.3% | |
Shares outstanding (eoy) | m | 24.69 | 612.00 | 4.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 3.2 | 134.9% | |
Avg P/E ratio | x | 15.7 | 673.3 | 2.3% | |
P/CF ratio (eoy) | x | 14.9 | 217.5 | 6.8% | |
Price / Book Value ratio | x | 2.1 | 2.6 | 80.7% | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 1,545 | 1,052.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 1 | 42,939.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 486 | 780.0% | |
Other income | Rs m | 581 | 857 | 67.8% | |
Total revenues | Rs m | 4,369 | 1,342 | 325.5% | |
Gross profit | Rs m | 651 | -816 | -79.8% | |
Depreciation | Rs m | 61 | 5 | 1,259.9% | |
Interest | Rs m | 18 | 35 | 49.8% | |
Profit before tax | Rs m | 1,154 | 1 | 102,106.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | -1 | -10,273.5% | |
Profit after tax | Rs m | 1,034 | 2 | 45,135.4% | |
Gross profit margin | % | 17.2 | -168.0 | -10.2% | |
Effective tax rate | % | 10.4 | -103.4 | -10.1% | |
Net profit margin | % | 27.3 | 0.5 | 5,775.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 2,594 | 303.0% | |
Current liabilities | Rs m | 2,683 | 1,987 | 135.0% | |
Net working cap to sales | % | 136.7 | 125.1 | 109.3% | |
Current ratio | x | 2.9 | 1.3 | 224.4% | |
Inventory Days | Days | 1,201 | 13 | 8,916.7% | |
Debtors Days | Days | 35 | 1,021,236,947 | 0.0% | |
Net fixed assets | Rs m | 12,656 | 38 | 32,889.6% | |
Share capital | Rs m | 123 | 612 | 20.2% | |
"Free" reserves | Rs m | 7,634 | -17 | -43,947.0% | |
Net worth | Rs m | 7,757 | 595 | 1,304.5% | |
Long term debt | Rs m | 0 | 54 | 0.0% | |
Total assets | Rs m | 20,517 | 2,634 | 778.9% | |
Interest coverage | x | 66.9 | 1.0 | 6,486.2% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.2 | 0.2 | 100.1% | |
Return on assets | % | 5.1 | 1.4 | 360.8% | |
Return on equity | % | 13.3 | 0.4 | 3,453.6% | |
Return on capital | % | 15.1 | 5.6 | 270.5% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 469 | 95.6% | |
From Investments | Rs m | -1,533 | 20 | -7,791.1% | |
From Financial Activity | Rs m | -305 | -488 | 62.4% | |
Net Cashflow | Rs m | -1,389 | 0 | 1,263,000.0% |
Indian Promoters | % | 0.0 | 30.7 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | - | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 69.3 | 42.3% | |
Shareholders | 41,239 | 114,800 | 35.9% | ||
Pledged promoter(s) holding | % | 0.0 | 95.2 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | SHRENIK | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.87% | 0.00% | 0.45% |
1-Month | 0.85% | 0.00% | 2.55% |
1-Year | 81.60% | 0.00% | 56.14% |
3-Year CAGR | 17.51% | -18.54% | 15.22% |
5-Year CAGR | 8.12% | -41.48% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the SHRENIK share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of SHRENIK the stake stands at 30.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of SHRENIK .
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
SHRENIK paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of SHRENIK .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.